Your browser doesn't support javascript.
loading
The pros and cons of interferons for oncolytic virotherapy.
Geoffroy, Karen; Bourgeois-Daigneault, Marie-Claude.
Afiliação
  • Geoffroy K; Cancer axis and Institut du cancer de Montréal, Centre de recherche du CHUM- CRCHUM, 900 St-Denis Street, Viger Tower, Room R10.480, Montreal, Quebec, H2X0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Faculty of Medicine, Université de Montréal, 2900 Edouard-Montpetit Boulevard, Roger-Gaudry Building, Montreal, Quebec, H3T1J4, Canada.
  • Bourgeois-Daigneault MC; Cancer axis and Institut du cancer de Montréal, Centre de recherche du CHUM- CRCHUM, 900 St-Denis Street, Viger Tower, Room R10.480, Montreal, Quebec, H2X0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Faculty of Medicine, Université de Montréal, 2900 Edouard-Montpetit Boulevard, Roger-Gaudry Building, Montreal, Quebec, H3T1J4, Canada. Electronic address: marie-claude.bourgeois-daigneault@umontreal.ca.
Cytokine Growth Factor Rev ; 56: 49-58, 2020 12.
Article em En | MEDLINE | ID: mdl-32694051
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Limite: Humans Idioma: En Revista: Cytokine Growth Factor Rev Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Limite: Humans Idioma: En Revista: Cytokine Growth Factor Rev Ano de publicação: 2020 Tipo de documento: Article